SEC Form D · Amendment · filed July 3, 2019
Cingulate Therapeutics
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Marious 5. Sjulsen · New York, NYExecAnton P. Feingold · New York, NYExec · DirectorJeff Kellam · Longview, TXDirectorJustin N. Lorino · New York, NYDirectorWilliam P. Phelan · Albany, NYExecJames A. Henderson · New York, NYExec · DirectorBrent Adam · Milwaukee, WIDirectorStelios R. Papadopoulos · San Diego, CAExecDavid Bartelme · Milwaukee, WIDirectorDavid C. Michaels · Albany, NYExecThomas J. Marusak · Albany, NYDirectorGeorge A. Overholser · KIRKLAND, WADirectorJohn H. Cox · Schaumburg, ILExecArrun Kapoor · Durham, NCExecAlan Kelley · Durham, NCDirectorMark H. Sherman · Tiburon, CAExec · DirectorRonnie Wallace · Rome, GAExec · DirectorBryan Kelley · Rome, GAExecPaul R. Marcus · Boston, MAExecChris S. Varin · Colchester, VTDirectorDana Arrighi · Orlando, FLDirectorTerrance Berland · Orlando, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗